Refine Search
(39)
(70)
(181)
(358)

Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016’, provides an overview of the Charcot-Marie-Tooth Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Neurofibromatoses - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neurofibromatoses - Pipeline Review, H2 2016’, provides an overview of the Neurofibromatoses pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Neurofibro...

Gaucher Disease Type III - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gaucher Disease Type III - Pipeline Review, H2 2016’, provides an overview of the Gaucher Disease Type III pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Charcot-Marie-Tooth Disease Type I A - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type I A - Pipeline Review, H2 2016’, provides an overview of the Charcot-Marie-Tooth Disease Type I A pipeline landscape.

The report provides comprehensive information on the therape...

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2017

  • $2,000
  • August 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2017’, provides an overview of the Sandhoff Disease (Jatzkewitz-Pilz Syndrome) pipeline landscape.

The report provides comprehensive information ...

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017

  • $2,000
  • June 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017’, provides an overview of the Opioid-Induced Bowel Dysfunction (OBD or OIBD) pipeline landscape.

The report provides comprehensive inform...

Barth Syndrome - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Barth Syndrome - Pipeline Review, H2 2018’, provides an overview of the Barth Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Barth Syndrome, ...

Gaucher Disease - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gaucher Disease - Pipeline Review, H1 2018’, provides an overview of the Gaucher Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gaucher Diseas...

Usher Syndrome - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Usher Syndrome - Pipeline Review, H1 2018’, provides an overview of the Usher Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Usher Syndrome, ...

Wilson Disease - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Wilson Disease - Pipeline Review, H1 2018’, provides an overview of the Wilson Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Wilson Disease, ...

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) - Pipeline Review, H1 2018’, provides an overview of the Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) pipeline landscape.

The report provides comp...

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2018’, provides an overview of the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) pipeline landscape.

The report provides comprehensiv...

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2018’, provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) pipeline landscape.

The report provides comprehe...

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2018’, provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) pipeline landscape.

The report provi...

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H1 2018’, provides an overview of the Neurofibromatoses Type I (Von Recklinghausen’s Disease) pipeline landscape.

The report provides co...